Insider filing · ROIV
Eric Venker
President & Immunovant CEO
profile →
Roivant Sciences Ltd.
ROIV · Healthcare · 75 filings in 24 months
ticker →
Eric Venker sold $4.1M of Roivant Sciences (ROIV)
Executed Dec 27 2024, disclosed Dec 31 2024, 4 days later.
Value, as filed
$4.1M
354,604 sh across 2 lots
Executed
Dec 27 2024
the trade date, as filed
Disclosed
Dec 31 2024
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
EVEric Venker (President & Immunovant CEO) filed 17 Form 4 reports in the trailing twelve months (0 purchases, 17 sales, 1 filed past the two-business-day deadline), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $14.5M of ROIV (851,383 sh across 3 lots, as filed), executed Oct 15 2025.
The name
ROIVHealthcare · Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicine…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Eric Venker in ROIV
ROIVSALE
Roivant Sciences Ltd.
$7.2M200,000 sh across 2 lots
Exec Aug 28
Filed Sep 1 · 9:00 PM ET ROIVSALE Roivant Sciences Ltd. $7.0M
200,000 sh × $34.95
Exec Jul 27
Filed Jul 29 · 9:00 PM ET ROIVSALE Roivant Sciences Ltd. $6.6M
200,000 sh across 2 lots
Exec Jun 24
Filed Jun 26 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $6.1M
200,000 sh × $30.27
Exec May 22
Filed May 22 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $5.9M
200,000 sh × $29.59
Exec Apr 20
Filed Apr 22 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $5.6M
200,000 sh × $28.24
Exec Mar 17
Filed Mar 19 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $5.3M
200,000 sh × $26.49
Exec Feb 13
Filed Feb 18 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $4.4M
200,000 sh × $21.92
Exec Jan 12
Filed Jan 14 · 5:30 PM ET